NCT00919113 - Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Interstitial CystitisPainful Bladder Syndrome

Interventions

DRUG

2% sodium chondroitin sulfate

Weekly 20 mL Intravesical instillation

DRUG

Placebo

The identical buffer used in Uracyst for the same administration

Trial Locations (20)

12206

Albany

12601

Poughkeepsie

19104

Philadelphia

27103

Winston-Salem

31904

Columbus

33317

Plantation

33414

Wellington

48073

Royal Oak

60160

Melrose Park

60201

Evanston

73104

Oklahoma City

80211

Denver

80304

Boulder

83814

Coeur d'Alene

89148

Las Vegas

98043

Mountlake Terrace

06032

Farmington

07601

Englewood

08080

Sewell

08060

Woodlane